Table 2 Clinico-pathologic characteristics of 100 EOC patients and their association to LipB protein expression
LipB protein expression | |||||
|---|---|---|---|---|---|
|  | Total | score ≤ 1 | score = 2 | score = 3 | p-value |
n(%) | n(%) | n(%) | |||
Age at diagnosis (y) | Â | Â | Â | Â | Â |
≤60 | 48 | 22 (46) | 20 (42) | 6 (12) | 0.6 |
>60 | 52 | 19 (37) | 25 (48) | 8 (15) | Â |
Histological type | Â | Â | Â | Â | Â |
serous | 51 | 25 (49) | 17 (33) | 9 (18) | Â |
endometrioid | 17 | 5 (29) | 11 (65) | 1 (6) | Â |
clear cell | 11 | 6 (55) | 3 (27) | 2 (18) | Â |
mucinous | 3 | 0 | 1 (33) | 2 (67) | 0.3 |
mixed | 13 | 4 (31) | 9 (69) | 0 | Â |
undifferentiated | 5 | 1 (20) | 4 (80) | 0 | Â |
FIGO stage | Â | Â | Â | Â | Â |
I + II | 27 | 10 (37) | 13 (48) | 4 (15) |  |
III + IV | 73 | 31 (42) | 32 (44) | 10 (14) | 0.7 |
Histological grade | Â | Â | Â | Â | Â |
G1 | 5 | 1 (20) | 2 (40) | 2 (40) | Â |
G2 + G3 | 95 | 40 (42) | 43 (45) | 12 (13) | 0.2 |
Residual tumor (RT), cm | Â | Â | Â | Â | Â |
RT = 0 | 40 | 14 (35) | 21 (52) | 5 (13) |  |
RT > 0 | 60 | 27 (45) | 24 (40) | 9 (15) | 0.5 |
Presence of ascites | Â | Â | Â | Â | Â |
no | 44 | 19 (43) | 18 (41) | 7 (16) | Â |
yes | 56 | 22 (39) | 27 (48) | 7 (13) | 0.5 |
Lymph nodal involvement | Â | Â | Â | Â | Â |
negative | 51 | 16 (31) | 23 (45) | 12 (24) | Â |
positive | 26 | 13 (50) | 12 (46) | 1 (4) | 0.3 |
missing | 23 | 12 (52) | 10 (44) | 1 (4) | Â |